Not all clients with CLL demand therapy. Despite all latest developments, the iwCLL however suggests watchful observation for patients with asymptomatic illness.86 This recommendation is predicated on no less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both trials concluded that early https://situs-judi-mbl7713456.verybigblog.com/31818974/link-alternatif-mbl77-secrets